Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest rheumatoid arthritis Stories

2014-01-12 23:02:50

Wintertime weather can affect more than just your mood; it can have a significant impact on your health as well – particularly if you are among the 50 million adults suffering from arthritis in the US. Dr. Jack Waxman of NCMA’s FountainGrove Rheumatology can help you understand and manage the symptoms associated with arthritis including those worsened by cold weather. Santa Rosa, CA (PRWEB) January 12, 2014 Anyone who suffers from arthritis pain can tell you that their joints do...

2014-01-09 23:26:38

Dr. James Wells, of South Charlotte Dentistry, is excited about sharing information about Rheumatoid Arthritis as it relates to dental health with his patients and the community. (PRWEB) January 09, 2014 In recent years, we’ve learned more and more about the link between a healthy mouth and a healthy body. But now research is pointing to specific connections of certain types of bacteria and diseases, in particular Rheumatoid Arthritis (RA). Dr. James Wells, of South Charlotte...

2014-01-08 08:29:37

Adheron's lead product, Cadherin-11 inhibitor SDP051, is based on pioneering cell technology and may be used in various therapeutic indications of high unmet medical need SAN FRANCISCO, Jan. 8, 2014 /PRNewswire/ -- Adheron Therapeutics, a biotechnology company which focuses on leveraging pioneering technology that disrupts cell adhesion to treat a variety of diseases, announced the completion of the company's Phase 1 clinical trial for its leading Cad-11 inhibitor SDP051. Cad-11...

2014-01-07 13:41:44

In a new study of over 7,000 older Chinese women published online today in the journal Rheumatology, breastfeeding – especially for a longer duration – is shown to be associated with a lower risk of rheumatoid arthritis (RA). Specifically, it showed that women who had breastfed their children were around half as likely to have RA, compared to women who had never breastfed. The beneficial effects of breastfeeding for both mother and child are widely known, but previous studies on the...

2013-12-31 08:22:46

Following the Successful Utilization of A3 Adenosine Receptor Biomarker in Can-Fite's Phase IIb Rheumatoid Arthritis Study PETACH TIKVA, Israel, Dec. 31, 2013 /PRNewswire/ -- Can-Fite BioPharma Ltd. (TASE: CFBI), (NYSE MKT: CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today the following: The Company's subsidiary, OphthaliX Inc. (OTCQB: OPLI), will conduct a retrospective analysis...

2013-12-31 08:22:44

PETACH TIKVA, Israel, Dec. 31, 2013 /PRNewswire/ -- OphthaliX Inc. (OTCQB: OPLI), announced today that it will conduct a retrospective analysis of the Phase III Dry Eye Syndrome study data to determine if there is a correlation between the CF101 target, the A3 adenosine receptor, expression and patients' response to the drug. This analysis is based on recent positive data from a Phase IIb Rheumatoid Arthritis study of CF101 conducted by OphthaliX's parent company, Can-Fite BioPharma...

2013-12-30 23:24:22

Flexcin International, Inc. makers of USA made all natural health products creates new site for flagship brand, Flexcin with CM8®. Ft. Myers, Florida (PRWEB) December 30, 2013 - Flexcin International, Inc., the makers of all-natural health products including Flexcin with CM8®,a joint nutritional product that helps to alleviate the pain and stiffness associated with diseases like Arthritis and Fibromyalgia, launched a new website for Flexcin. The new website...

2013-12-30 00:20:21

PETACH TIKVA, Israel, Dec. 30, 2013 /PRNewswire/ -- Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. (OTCBB:OPLI) released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine...

More Than 40 New Genetic Links To Rheumatoid Arthritis Discovered
2013-12-26 08:06:07

redOrbit Staff & Wire Reports - Your Universe Online An international team of scientists has uncovered more than 40 new genes, pathways and cell types linked to an increased risk of rheumatoid arthritis, according to research published Wednesday in the online edition of the journal Nature. The study, which according to BBC News science correspondent Pallab Ghosh, is the largest genetic study ever completed, involving nearly 30,000 rheumatoid arthritis (RA) patients and more than...

2013-12-23 11:12:18

New research shows mortality rates are two times higher in postmenopausal women with rheumatoid arthritis (RA) and anti-cyclic citrullinated peptide (anti-CCP) antibodies. Findings published in the American College of Rheumatology (ACR) journal Arthritis & Rheumatism, soon to be called Arthritis & Rheumatology, indicate the higher mortality rates persisted after adjusting for age, positive rheumatoid factor, positive antinuclear antibodies (ANA) and disease modifying anti-rheumatic...